Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Socazolimab monotherapy in advanced urothelial carcinoma
NCT03676946Phase 2Unknown
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Oct 2018
- Primary completion
- Feb 2020
- Modality
- Immune Checkpoint Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of socazolimab in urothelial carcinoma (UC), sponsored by Lee's Pharmaceutical Holdings Limited. Status: unknown.
02
Drugs
socazolimab
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT03676946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03676946.